Umfassende klinische Entwicklung
Orforglipron has undergone extensive clinical development through rigorous Phase I, II, and III trials.
Our research program involved thousands of patients across multiple countries, ensuring robust data
collection and comprehensive safety profiling.
The clinical development process for Orforglipron followed international guidelines and regulatory
standards, with studies designed to evaluate efficacy, safety, and optimal dosing regimens across
diverse patient populations.
- Phase‑I‑Studien: Sicherheit, Verträglichkeit und Pharmakokinetik bei gesunden Freiwilligen
- Phase‑II‑Studien: Wirksamkeit und optimale Dosierung in Zielpopulationen
- Phase‑III‑Studien: Große randomisierte kontrollierte Studien zur Bestätigung klinischer Effekte
- Pharmakovigilanz nach Markteinführung: Fortlaufende Überwachung von Sicherheit und Wirksamkeit im Alltag
Scientific Innovation & Discovery
Our research team has dedicated years to understanding the molecular mechanisms and therapeutic
potential of Orforglipron. Through advanced laboratory research and translational studies, we've
gained deep insights into how this medication works at the cellular level.
The development of Orforglipron represents a significant advancement in pharmaceutical science,
combining cutting-edge molecular design with clinical expertise to create a treatment option
that addresses unmet medical needs.
50+
Klinische Studien
10,000+
Teilnehmende
15+
Länder
5+
Jahre Forschung
Global Collaboration Network
Our research efforts are strengthened through partnerships with leading academic institutions,
research organizations, and healthcare facilities worldwide. These collaborations enable us to
conduct comprehensive studies and share knowledge that advances the entire field of medicine.
We work closely with regulatory authorities, patient advocacy groups, and healthcare professionals
to ensure our research addresses real-world needs and contributes to improved patient outcomes
globally.
